Pathstone Family Office’s Labcorp LH Stock Holding History

Pathstone Family Office’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.36M	Buy	6,774 +2,318	+52%	+$489K	0.01%	597
2023 Q2	$968K	Buy	4,456 +205	+5%	+$39.8K	0.01%	499
2023 Q1	$851K	Sell	4,251 -7,615	-64%	-$1.57M	0.01%	497
2022 Q4	$2.09M	Buy	11,866 +2,513	+27%	+$491K	0.02%	491
2022 Q3	$1.65M	Buy	9,353 +7,415	+383%	+$1.52M	0.01%	514
2022 Q2	$390K	Buy	1,938 +525	+37%	+$112K	0.01%	681
2022 Q1	$319K	Sell	1,413 -54	-4%	-$12.7K	0.01%	725
2021 Q4	$397K	Sell	1,467 -5,765	-80%	-$1.43M	0.01%	625
2021 Q3	$1.75M	Buy	7,232 +5,819	+412%	+$1.47M	0.05%	186
2021 Q2	$335K	Buy	+1,413	New	+$322K	0.01%	610
2021 Q1	–	Sell	-457	Closed	-$80K	–	1037
2020 Q4	$80K	Hold	457	–	–	﹤0.01%	432
2020 Q3	$74K	Hold	457	–	–	0.01%	315
2020 Q2	$65K	Hold	457	–	–	0.01%	279
2020 Q1	$50K	Sell	457 -62	-12%	-$8.93K	0.01%	312
2019 Q4	$753K	Buy	519 +22	+4%	+$3.18K	0.01%	236
2019 Q3	$71K	Hold	497	–	–	0.01%	221
2019 Q2	$73K	Buy	497 +58	+13%	+$8.09K	0.01%	280
2019 Q1	$58K	Buy	+439	New	+$54.1K	0.01%	287
2017 Q2	–	Sell	-12	Closed	-$1K	–	534
2017 Q1	$1K	Buy	+12	New	+$1.42K	﹤0.01%	486

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pathstone Family Office's LH Position: Q3 2023 in Review

Pathstone Family Office increased its Labcorp (LH) stake by 52% in Q3 2023, buying an estimated $489K and bringing the position to 6,774 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #597.

Pathstone Family Office first reported a position in LH in Q1 2017 and has held it in 19 quarters since. The position peaked at $2.09M in Q4 2022. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.

Pathstone Family Office held 6,774 shares of Labcorp worth $1.36M as of Q3 2023.
Pathstone Family Office bought 2,318 Labcorp shares in Q3 2023, an estimated $489K.
Labcorp made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #597 holding.
Pathstone Family Office first reported a position in Labcorp in Q1 2017 and has held it in 19 quarters since.
Pathstone Family Office's Labcorp position peaked at $2.09M in Q4 2022.
881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.